Enhancer ID: | E_01_0346 |
Species: | human |
Position : | chr3:189628751-189630751 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Mammary cancer |
Pubmed ID: | 30563971 |
Enhancer experiment: | PCR?Western blot?ChIP-seq |
Enhancer experiment description: | We further identified that the TP63 gene was repressed by this precision-guided machinery of TRPS1-CHD4/NuRD(MTA2) complex, which decommissions its enhancer leading to a decrease in ?Np63 and enhancing the metastatic ability of breast cancer cells. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | We further identified that the TP63 gene was repressed by this precision-guided machinery of TRPS1-CHD4/NuRD(MTA2) complex, which decommissions its enhancer leading to a decrease in ?Np63 and enhancing the metastatic ability of breast cancer cells. |
TF name : | TP63(AIS,B(p51A),B(p51B),EEC3,KET,LMS,NBP,OFC8,RHS,SHFM4,TP53CP,TP53L,TP73L,p40,p51,p53CP,p63,p73H,p73L) |
TF experiment: | PCR?Western blot?ChIP-seq |
TF experiment description: | We further identified that the TP63 gene was repressed by this precision-guided machinery of TRPS1-CHD4/NuRD(MTA2) complex, which decommissions its enhancer leading to a decrease in ?Np63 and enhancing the metastatic ability of breast cancer cells. |
Enhancer function : | We further identified that the TP63 gene was repressed by this precision-guided machinery of TRPS1-CHD4/NuRD(MTA2) complex, which decommissions its enhancer leading to a decrease in ?Np63 and enhancing the metastatic ability of breast cancer cells. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
We further identified that the TP63 gene was repressed by this precision-guided machinery of TRPS1-CHD4/NuRD(MTA2) complex, which decommissions its enhancer leading to a decrease in ?Np63 and enhancing the metastatic ability of breast cancer cells. |
SNP ID: | -- |